Aldactone

Main information

  • Trade name:
  • Aldactone 25 mg Film coated tablet
  • Dosage:
  • 25 mg
  • Pharmaceutical form:
  • Film coated tablet
  • Units in package:
  • Blister pack, 100 tablets
  • Class:
  • Prescription
  • Prescription type:
  • Prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Piramal Healthcare UK Limited

Documents

Localization

  • Available in:
  • Aldactone 25 mg Film coated tablet
    New Zealand
  • Language:
  • English

Therapeutic information

  • Therapeutic indications:
  • Essential hypertension; oedematous conditions including congestive cardiac failure, cirrhosis of the liver, (with or without ascites) and the nephrotic syndrome; diagnosis and treatment of primary aldosteronism, as adjunctive therapy in malignant hypertension; in diuretic induced hypokalaemia/hypomagnesaemia when other measures are considered inappropriate or inadequate; prophylaxis of hypokalaemia in patients taking digitalis when other measures are considered inadequate or inappropriate, hirsutism.

Other information

Status

  • Source:
  • Medsafe - Medicines Safety Authority - New Zealand
  • Authorization number:
  • 1339
  • Authorization date:
  • 31-12-1969
  • Last update:
  • 27-09-2017

28-8-2018

Accord Healthcare Inc. Issues Voluntary Nationwide Recall of Hydrochlorothiazide Tablets USP 12.5 Mg Due to Labeling Mix-up

Accord Healthcare Inc. Issues Voluntary Nationwide Recall of Hydrochlorothiazide Tablets USP 12.5 Mg Due to Labeling Mix-up

A 100 count bottle of Hydrochlorothiazide Tablets USP 12.5 mg has been found to contain 100 Spironolactone Tablets USP 25 mg. Since the individual lot, PW05264, of the product is involved in a potential mix-up of labeling, Accord is recalling this individual lot from the market.

FDA - U.S. Food and Drug Administration